GO:1901028 regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway: Apoptotic Pore Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901028 describes any process that modulates the frequency, rate or extent of mitochondrial outer membrane permeabilization (MOMP) during apoptotic signaling.
• MOMP is executed by BCL-2 family effector proteins BAX and BAK, which oligomerize to form pores in the mitochondrial outer membrane.
• The BCL-2 family is divided into anti-apoptotic guardians (BCL-2, BCL-XL, MCL-1), effectors (BAX, BAK, BOK) and BH3-only sensitizers/activators (BID, BIM, PUMA, NOXA) that collectively set the apoptotic threshold.
• Regulation of MOMP is central to chemotherapy responses, neurodegeneration, ischemia-reperfusion injury and immune homeostasis.
• Metabolic inputs such as ceramide metabolism and hexokinase-VDAC binding directly tune MOMP sensitivity.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for dissecting causal roles of MOMP regulators.
Description
Mitochondrial outer membrane permeabilization (MOMP) is the point of no return in the intrinsic apoptotic pathway, and GO:1901028 captures every process that modulates its frequency, rate or extent during apoptotic signaling. When MOMP occurs, soluble intermembrane-space proteins such as cytochrome c are released into the cytosol, triggering caspase activation and cell death. Because the decision to permeabilize is tightly controlled, the regulators annotated to GO:1901028 act as a rheostat that determines whether a cell lives or dies. Understanding this regulatory node is therefore essential for cancer biology, neurobiology and drug development. The core machinery is the BCL-2 family. Effectors BAX and BAK undergo conformational activation, membrane insertion and oligomerization to form the apoptotic pore, while anti-apoptotic proteins BCL-2, BCL-XL and MCL-1 sequester them. BH3-only proteins such as BID, BIM, PUMA and NOXA either activate effectors directly or displace them from guardians, thereby regulating MOMP. BOK is a less-characterized effector that can form large toroidal pores and is promoted by cBID. Beyond the BCL-2 family, metabolic and structural inputs regulate MOMP. Ceramide metabolism modulates outer membrane permeabilization and apoptosis, and hexokinase binding to VDAC at the mitochondrial surface influences the permeability transition and apoptotic sensitivity. These layers make GO:1901028 a convergence point for signals ranging from DNA damage to metabolic stress.
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway At A Glance
| GO ID | GO:1901028 |
|---|---|
| GO term | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of mitochondrial outer membrane permeabilization; regulation of MOMP |
| Definition | Any process that modulates the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
| Major function | Sets the threshold for intrinsic apoptosis by controlling BAX/BAK pore formation and cytochrome c release. |
| Key effectors | BAX, BAK, BOK |
| Key regulators | BCL-2, BCL-XL, MCL-1, BID, BIM, PUMA, NOXA |
| Upstream inputs | DNA damage, BH3-only activation, ceramide metabolism, hexokinase-VDAC binding |
What Is GO:1901028?
GO:1901028, regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway, is a biological process term defined as any process that modulates the frequency, rate or extent of mitochondrial outer membrane permeabilization during apoptotic signaling. In practice, it covers the molecular events that set the threshold, timing and extent of pore formation in the mitochondrial outer membrane, including activation or inhibition of BAX/BAK, sequestration by anti-apoptotic BCL-2 proteins, and BH3-only protein signaling.
Why Is regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway Important in Cell Biology?
Regulation of MOMP is the decisive step that commits a cell to intrinsic apoptosis, so its dysregulation underlies chemotherapy resistance in cancer, inappropriate cell death in neurodegeneration and ischemia-reperfusion injury, and autoimmune or immunodeficiency phenotypes. Because GO:1901028 regulators are druggable and genetically tractable, they are among the most studied targets in cell-death research.
• Defines the commitment point of intrinsic apoptosis and therefore cell fate.
• Determines sensitivity or resistance to chemotherapy and targeted therapies.
• BH3-mimetic drugs such as venetoclax act by modulating MOMP regulators.
• Loss of MOMP effectors BAX/BAK causes profound apoptotic resistance.
• Ceramide metabolism can shift the MOMP threshold and alter apoptosis.
• Hexokinase-VDAC interaction links glycolysis to MOMP regulation.
• Relevant to neurodegeneration where excessive MOMP drives neuronal loss.
• Relevant to ischemia-reperfusion injury in heart and brain.
• Provides biomarkers and targets for cancer prognosis and therapy.
• Central to immune cell homeostasis and autoimmunity.
What Happens During regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway?
Sensing apoptotic signals and BH3-only activation
In simple terms: Stress signals wake up BH3-only proteins that decide whether the cell should die.
Apoptotic stimuli such as DNA damage or oncogenic stress transcriptionally and post-translationally activate BH3-only proteins including BIM, PUMA, NOXA, BID and BMF. These proteins act as sensors that either directly activate BAX/BAK or neutralize anti-apoptotic BCL-2 proteins, thereby regulating the onset of MOMP.
Effector activation and pore formation
In simple terms: BAX and BAK change shape, insert into the mitochondrial outer membrane and punch holes in it.
Upon activation, cytosolic BAX undergoes conformational change, mitochondrial translocation, membrane insertion and oligomerization; BAK is already membrane-bound and similarly oligomerizes. BOK can also form large, stable toroidal pores, a process promoted by cBID. The resulting pore releases cytochrome c and other intermembrane-space proteins.
Anti-apoptotic guardians and threshold setting
In simple terms: Guardian proteins hold the executioners in check until the stress is strong enough.
BCL-2, BCL-XL and MCL-1 bind and sequester activated BAX/BAK and BH3-only proteins, raising the threshold for MOMP. The balance between guardians, effectors and BH3-only proteins determines whether MOMP proceeds, making this equilibrium the core of GO:1901028 regulation.
Metabolic and structural modulation of MOMP
In simple terms: The cell's metabolic state and membrane contacts also tune how easily mitochondria leak.
Ceramide metabolism modulates MOMP and apoptosis, linking sphingolipid signaling to pore regulation. Hexokinase binding to VDAC at the outer membrane influences apoptotic sensitivity and permeability. These inputs integrate metabolic status with the BCL-2 family network to fine-tune MOMP.
Downstream consequences of MOMP
In simple terms: Once the membrane leaks, the cell activates caspases and dismantles itself.
Cytochrome c released after MOMP assembles the apoptosome with APAF-1 and caspase-9, activating effector caspases that execute apoptosis. MOMP is therefore both the regulatory endpoint of GO:1901028 and the trigger for irreversible cell death.
Key Genes Involved in GO:1901028 regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
The genes most directly implicated in regulating MOMP are the BCL-2 family members and their metabolic modulators, as documented in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BAX | Effector that oligomerizes to form the apoptotic pore | Core executioner; knockout confers apoptotic resistance |
| BAK | Membrane-bound effector that oligomerizes during MOMP | Redundant with BAX; double KO blocks MOMP |
| BOK | Effector forming large toroidal pores, promoted by cBID | Less-studied effector; relevant in cancer and neurodegeneration |
| BCL-2 | Anti-apoptotic guardian sequestering BAX/BAK | Target of venetoclax; overexpression blocks MOMP |
| BCL-XL | Anti-apoptotic guardian | Determines platelet and neuronal survival |
| MCL-1 | Anti-apoptotic guardian with short half-life | Key resistance factor in many cancers |
| BID | BH3-only activator; cBID promotes BOK pores | Links extrinsic and intrinsic apoptosis |
| BIM | BH3-only activator/sensitizer | Required for many developmental apoptosis programs |
| PUMA | BH3-only activator downstream of p53 | Mediates DNA-damage-induced apoptosis |
| NOXA | BH3-only sensitizer targeting MCL-1 | Modulates chemosensitivity |
| BMF | BH3-only sensitizer | Links cytoskeletal stress to MOMP |
| BAD | BH3-only sensitizer | Integrates growth factor signaling |
| HRK | BH3-only sensitizer | Tissue-specific apoptosis regulator |
| VDAC | Outer membrane channel modulated by hexokinase | Links metabolism to MOMP |
| HK2 | Hexokinase binding VDAC to modulate apoptosis | Glycolysis-apoptosis crosstalk |
| Ceramide synthases | Ceramide metabolism modulates MOMP | Sphingolipid control of apoptosis |
| APAF-1 | Apoptosome scaffold downstream of MOMP | Readout of MOMP-mediated caspase activation |
| CASP9 | Initiator caspase activated by cytochrome c | Effector of MOMP downstream signaling |
How Is regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway Regulated?
MOMP regulation is controlled by the balance of BCL-2 family proteins and by upstream signaling that modifies them. Transcriptional induction of BH3-only proteins by p53 and other stress transcription factors raises MOMP sensitivity, while anti-apoptotic guardian overexpression lowers it. Post-translational modifications such as phosphorylation and cleavage (for example, BID cleavage to cBID) tune effector activity. Metabolic regulators including ceramide metabolism and hexokinase-VDAC binding further modulate the threshold.
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL-2 | Lymphoma and leukemia; venetoclax target | Overexpression and point-mutation knock-in in cancer lines |
| MCL-1 | Multiple cancers with chemoresistance | Knockout and inducible degradation models |
| BAX | Apoptotic resistance in tumors | Knockout and oligomerization-deficient point mutants |
| BAK | Apoptotic resistance; redundant with BAX | Double knockout with BAX |
| BOK | Cancer and neurodegeneration | Knockout and pore-formation point mutants |
Cancer and chemoresistance
Tumors frequently overexpress anti-apoptotic BCL-2, BCL-XL or MCL-1 to suppress MOMP and evade apoptosis, which drives chemoresistance. Conversely, loss of BAX or BAK can render cells refractory to diverse apoptotic stimuli. BH3-mimetic drugs were designed to restore MOMP regulation and are now standard in several hematologic malignancies.
Neurodegeneration
Excessive or inappropriate MOMP contributes to neuronal loss in acute and chronic neurodegenerative conditions, where BH3-only proteins and BAX are activated. Modulating MOMP regulators is therefore considered a neuroprotective strategy in preclinical models.
Ischemia-reperfusion injury
In heart and brain ischemia-reperfusion, mitochondrial cell death pathways including MOMP amplify tissue damage. Inhibiting MOMP effectors or enhancing guardians has been explored to limit infarct size in experimental systems.
Metabolic and sphingolipid disorders
Ceramide metabolism directly modulates MOMP, linking sphingolipid disorders to apoptotic sensitivity. Hexokinase-VDAC interactions also connect altered glucose metabolism to MOMP regulation in disease states.
From regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a gene required for MOMP? | CRISPR knockout of BAX, BAK or BOK in cancer cell lines |
| Does a specific residue control pore formation? | Point-mutation knock-in of BAX/BAK oligomerization residues |
| Does a guardian protein set the apoptotic threshold? | Overexpression of BCL-2, BCL-XL or MCL-1 |
| Where does a regulator localize during MOMP? | Tagged knock-in with fluorescent or epitope tags |
| Does a metabolic enzyme modulate MOMP? | Knockout or overexpression of HK2 or ceramide enzymes |
| Can a drug restore MOMP? | BH3-mimetic treatment in guardian-overexpressing models |
How to Study the regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cytochrome c release assay | MOMP occurrence | Drug and genetic perturbation studies |
| Live-cell imaging of BAX/BAK | Effector activation and oligomerization | Real-time MOMP dynamics |
| BH3 profiling | Mitochondrial priming and apoptotic threshold | Predicting chemosensitivity |
| Co-immunoprecipitation | BCL-2 family interactions | Mapping sequestration vs activation |
| Caspase-3/7 activity assay | Downstream apoptosis execution | Confirming MOMP functional consequence |
| Lipidomics | Ceramide species modulating MOMP | Sphingolipid-apoptosis crosstalk |
| Hexokinase-VDAC binding assay | Metabolic modulation of MOMP | Glycolysis-apoptosis studies |
| Clonogenic survival | Long-term effect of MOMP regulation | Therapeutic response modeling |
Measuring MOMP directly
MOMP is commonly assessed by cytochrome c release, mitochondrial outer membrane permeabilization assays, and live-cell imaging of fluorescently tagged BAX/BAK. These readouts define whether a perturbation changes the frequency or extent of pore formation.
Protein interaction and conformational analysis
Co-immunoprecipitation, crosslinking and conformational-specific antibodies detect BAX activation and BCL-2 family interactions that regulate MOMP. Such assays reveal whether a candidate regulator acts by sequestration or direct activation.
Functional apoptosis assays
Annexin V staining, caspase-3/7 activity and clonogenic survival link MOMP regulation to cell fate. BH3 profiling measures mitochondrial priming and predicts drug response.
Metabolic and lipid profiling
Lipidomics and metabolic flux analysis quantify ceramide species and hexokinase-VDAC binding that modulate MOMP. These methods connect metabolic state to apoptotic threshold.
How CRISPR Can Be Used to Study GO:1901028 regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
Knockout
CRISPR knockout of BAX, BAK, BOK or guardian genes is used to test necessity for MOMP and apoptosis. Double knockout of BAX and BAK is a classic model of apoptotic resistance.
Point Mutation
Point-mutation knock-in of residues required for BAX/BAK conformational change or oligomerization dissects pore-formation mechanisms without deleting the protein. Such models are essential for structure-function studies of MOMP regulators.
Knock-in
Tagged knock-in of BCL-2 family members enables live-cell imaging and interaction mapping during MOMP. Knock-in of disease-associated variants can model altered apoptotic thresholds.
Overexpression
Overexpression of anti-apoptotic guardians such as BCL-2 or MCL-1 raises the MOMP threshold and models chemoresistance. Overexpression of BH3-only proteins lowers the threshold and sensitizes cells to apoptosis.
How EDITGENE Supports regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway Research
Researchers studying regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in setting the apoptotic threshold, and CRISPR-based models provide the cleanest way to establish that causality.
Contact EDITGENE today to design your custom CRISPR model for regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway research.
Frequently Asked Questions About regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
What is GO:1901028?
GO:1901028 is the biological process term for regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway, covering any process that modulates the frequency, rate or extent of MOMP during apoptosis.
What genes are involved in regulation of mitochondrial outer membrane permeabilization?
The main genes are BCL-2 family members including BAX, BAK, BOK, BCL-2, BCL-XL, MCL-1, BID, BIM, PUMA and NOXA, plus metabolic modulators such as VDAC, hexokinase and ceramide enzymes.
What is mitochondrial outer membrane permeabilization (MOMP)?
MOMP is the formation of pores in the mitochondrial outer membrane by BAX/BAK that releases cytochrome c and commits the cell to apoptosis.
How is MOMP regulated?
MOMP is regulated by the balance between anti-apoptotic guardians, effector proteins and BH3-only proteins, and by metabolic inputs such as ceramide metabolism and hexokinase-VDAC binding.
Why is regulation of MOMP important in cancer?
Cancer cells often overexpress anti-apoptotic proteins to suppress MOMP and resist chemotherapy, making MOMP regulators key drug targets such as venetoclax.
What is the role of BAX and BAK in MOMP?
BAX and BAK are the effector proteins that oligomerize to form the apoptotic pore; their loss causes apoptotic resistance.
How can I study MOMP regulation in the lab?
Common methods include cytochrome c release assays, live-cell imaging of BAX/BAK, BH3 profiling, caspase activity assays and lipidomics.
What is BOK and how does it relate to MOMP?
BOK is a BCL-2 family effector that can form large toroidal pores, and its membrane activity is promoted by cBID.
Does ceramide metabolism affect MOMP?
Yes, ceramide metabolism modulates mitochondrial outer membrane permeabilization and apoptosis.
How does hexokinase binding to VDAC influence apoptosis?
Hexokinase binding to VDAC at the mitochondrial outer membrane regulates permeability and apoptotic sensitivity.
Conclusion
GO:1901028 captures the regulatory control of MOMP, the decisive step in intrinsic apoptosis. Its core machinery, the BCL-2 family, integrates developmental, stress and metabolic signals to set the apoptotic threshold. Dysregulation of this process underlies cancer chemoresistance, neurodegeneration and ischemia-reperfusion injury, making its components important therapeutic targets. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with functional and imaging assays, provide the tools needed to dissect and exploit this pathway.
References
- 1. Bock FJ et al.. 2020. Mitochondria as multifaceted regulators of cell death.. Nat Rev Mol Cell Biol 21(2):85-100 PMID: 31636403
- 2. Dadsena S et al.. 2021. Mechanisms of mitochondrial cell death.. Biochem Soc Trans 49(2):663-674 PMID: 33704419
- 3. Flores-Romero H et al.. 2020. Pore formation in regulated cell death.. EMBO J 39(23):e105753 PMID: 33124082
- 4. Renault TT et al.. 2011. Bax: Addressed to kill.. Biochimie 93(9):1379-91 PMID: 21641962
- 5. Fernández-Marrero Y et al.. 2017. The membrane activity of BOK involves formation of large, stable toroidal pores and is promoted by cBID.. FEBS J 284(5):711-724 PMID: 28064468
- 6. Rego A et al.. 2012. Modulation of mitochondrial outer membrane permeabilization and apoptosis by ceramide metabolism.. PLoS One 7(11):e48571 PMID: 23226203
- 7. Green DR et al.. 2004. The pathophysiology of mitochondrial cell death.. Science 305(5684):626-9 PMID: 15286356
- 8. Pastorino JG et al.. 2008. Regulation of hexokinase binding to VDAC.. J Bioenerg Biomembr 40(3):171-82 PMID: 18683036
